GAM SYSTEMATIC LLP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 140 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
GAM SYSTEMATIC LLP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2016$179,000,000
+5866.7%
15,180
+9212.9%
0.04%
+3700.0%
Q1 2016$3,000,000
-96.3%
163
-94.2%
0.00%
-95.7%
Q4 2015$81,000,000
+710.0%
2,815
+737.8%
0.02%
+1050.0%
Q3 2015$10,000,0003360.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
Orbimed Advisors 3,028,354$30,526,0000.37%
Engineers Gate Manager LP 96,105$969,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 61,600$621,0000.06%
GAM Holding AG 83,940$846,0000.03%
SHELL ASSET MANAGEMENT CO 90,282$910,0000.02%
SFMG, LLC 11,994$107,0000.02%
QS Investors, LLC 159,133$1,604,0000.02%
Winslow, Evans & Crocker, Inc. 4,060$42,0000.01%
PANAGORA ASSET MANAGEMENT INC 285,646$2,879,0000.01%
PEAK6 Investments LLC 225,800$2,276,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders